Funding Grows For Indy-Connected Biopharma Company

Posted: Updated:
Outpost Medicine was launched in 2016. Outpost Medicine was launched in 2016.
INDIANAPOLIS and LONDON -

A biopharmaceutical company with offices in Indianapolis and London has announced a $20 million boost to a Series A round of financing. Outpost Medicine, which focuses on treating urologic and gastrointestinal disorders, also says Scott Byrd will succeed co-founder David Socks as president and chief executive officer. Socks, who also serves as a venture partner with one of Outpost's key VC providers, Frazier Healthcare Partners, will remain on the board of directors.

Byrd most recently served as president and chief operating officer of United Kingdom-based Acacia Pharma Inc. and his 25 years of pharmaceutical industry experience also includes time as senior vice president and chief commercial officer of Mallinckrodt PLC (NYSE: MNK) subsidiary Cadence Pharmaceuticals and various positions at Indianapolis-based Eli Lilly and Co. (NYSE: LLY).

The company's Series A total is now valued at $61 million. New investor Takeda Ventures joined existing Outpost investors Frazier Healthcare Partners, Novo Holdings A/S, Vivo Capital and Adams Street Partners on the extended financial backing.

Outpost Chairman Tachi Yamada says "Scott has a proven record of success across commercialization, development, manufacturing, and capital markets, which we expect will greatly benefit Outpost as we advance our pipeline of novel therapeutics." He adds "proceeds from the Series A extension enable Outpost to shift focus to OP-687, a new class of oral therapy in development for the treatment overactive bladder and irritable bowel syndrome. We believe OP-687 holds great potential to significantly improve the care of patients with OAB and IBS, disorders that affect over 1 in 10 people worldwide."

The company was formed in March of 2016 through a partnership with Japan-based Takeda Pharmaceutical Co. Ltd. and Frazier Healthcare Partners. Outpost was launched as the exclusive global development and commercialization licensee of a clinical-stage candidate being studied to treat stress urinary incontinence called OP-233. In the company's announcement of its funding extension, it also announced the discontinuation of the OP-233 program.

  • Perspectives

    • Want to Build a Culture of Experimentation? Embrace Failure First

      Failure. It’s not something all business leaders are comfortable embracing, yet it’s integral to success. That’s because failure signals attempt - and without those undertakings, none of the world’s greatest inventions would have ever come to fruition. So when company leaders decide they want to cultivate a culture of experimentation within their company, it’s important they understand the value of embracing failure. It’s not only a great way to...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Scotty's Brewhouse Files For Bankruptcy

      Indianapolis-based Scotty's Brewhouse has filed for Chapter 11 bankruptcy protection. The company says the decision was "driven largely by the challenges of some specific locations and was necessary because of the way the company was structured corporately." As a result of the deal, Scotty's will close four of its restaurants by the end of the year. In a news release provided to Inside INdiana Business...

    • Indy Airport to Introduce New Airline

      Indianapolis International Airport will today host an event to welcome a new airline. Airport officials say the provider will add more routes to IND's growing roster of options. Earlier this month, the airport reported record-breaking traffic in the third quarter. IND said the more than 2.4 million passengers that passed through the airport in the third quarter of 2018 marked an 8 percent year-to-date increase over last year and the best third quarter in the facility's history.

    • FFA Bid Draws 'Fierce' Competition

      Visit Indy says the National FFA Organization's decision to keep its annual convention in Indianapolis is the result of nearly a year of negotiations. The Indy-based organization Tuesday announced Indianapolis would continue to host the event through 2031. Chris Gahl, senior vice president of marketing and communications with Visit Indy, says the FFA needed to book the convention that far out for various reasons, including date availability, space requirements and the competitive...

    • Churubusco Company Acquired

      Cleveland-based Lincoln Electric Holdings Inc. (Nasdaq: LECO) has announced the acquisitions of two companies, one of which is located in Whitley County. Financial terms of the deal for Churubusco-based Pro Systems LLC and Coldwater Machine Company LLC in Ohio are not being disclosed.

    • IND Adds New Airline, Nonstop Routes

      A Florida-based airline, billing itself as an "ultra low-cost carrier," is coming to Indianapolis International Airport. Spirit Airlines Inc. (NYSE: SAVE) will begin daily, nonstop service to Las Vegas and Orlando in March, and add summer seasonal nonstop service to Myrtle Beach in May. Vice President For Capacity Planning Mark Kopczak says the airline sees "real potential for growth" in those routes, adding IND has done a good job "selling Indy as a place...